Konkurencja i konsument · 10/08/2016

Antitrust Regulators Grant Early Termination of Waiting Period for Merger Between Pfizer and Mylan

The Federal Trade Commission has approved Pfizer's request to end the waiting period for its proposed acquisition of Mylan, a move that clears the way for the $8.8 billion deal to close